For nearly 40 years, TCT has set the pace for interventional cardiovascular medicine. Organized by the Cardiovascular Research Foundation and held October 31–November 3, 2026, at the San Diego Convention Center, it is the world’s premier symposium for late-breaking clinical trial data on transcatheter and structural heart procedures. Every major shift in how the field treats valve disease, coronary intervention, and left atrial appendage closure gets debated here first.
Why Avania is there: Avania’s clinical, regulatory, and market access experts work this space every day, running trials and building regulatory strategy for the structural heart and interventional devices being discussed on TCT’s main stage. If your team is navigating a transcatheter program toward FDA clearance or CE Mark, or building the clinical evidence structural heart devices need to reach patients, we should talk.
The Cardiovascular team will be onsite across all four days. Schedule time with our team.